Navigation Links
Mylan Launches Generic Version of Cyklokapron® Injection
Date:12/2/2011

PITTSBURGH, Dec. 2, 2011 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Tranexamic Acid Injection, 100 mg/mL, packaged in 1,000 mg/10 mL Single-dose Vials. This product is the generic version of Pharmacia & Upjohn's Cyklokapron® Injection, which is indicated for short-term use in patients with hemophilia to reduce or prevent hemorrhage during and following oral surgery.

Tranexamic Acid Injection had U.S. sales of approximately $17 million for the 12 months ending Sept. 30, 2011, according to IMS Health. Mylan is shipping this product immediately.

Currently, Mylan has 165 ANDAs pending FDA approval representing $99.4 billion in annual sales, according to IMS Health. Forty-three of these pending ANDAs are potential first-to-file opportunities, representing $26.9 billion in annual brand sales, for the 12 months ending June 30, 2011, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS
2. Mylan Launches Generic Version of Caduet® Tablets
3. Mylan Confirms First-to-File Patent Challenge Relating to Generess™ Fe
4. Mylan Committed to Expanding Access in Developing Countries to High Quality, Affordable HIV/AIDS Treatment
5. Mylan Receives Approval for Generic Version of Zinecard® for Injection
6. Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot®
7. Mylan Successfully Upsizes and Completes Refinancing of Credit Facility
8. Mylan Applauds Obama Administrations Call to Create an "AIDS-Free Generation" Through Global Fight Against HIV/AIDS
9. Mylan to Acquire Pfizer Respiratory Delivery Platform
10. Mylan Receives Approval for Generic Version of MS Contin® Tablets
11. Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Inc. (NASDAQ: ATOS ), The Breast Health Company™, ... Financial Officer & General Counsel, will present at the Second ... in New York City at the ... scheduled to begin at 3:30 p.m. EDT and will be ... to www.atossagenetics.com . For more information and ...
(Date:5/16/2013)... SINGAPORE and ZURICH , May ... Agency for Science, Technology and Research (A*STAR) and ... the first healthy volunteer has been dosed in a Phase ... on Cytos, proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In ... of this novel vaccine candidate and its potential to protect ...
(Date:5/16/2013)... SYDNEY , May 16, 2013  HeartWare ... a leading innovator of less invasive, miniaturized circulatory support technologies ... announced that CEO Doug Godshall is ... at 11:00 a.m. EDT on Monday, May 20, 2013.  The ... New York Hotel. A live webcast of the ...
Breaking Medicine Technology:Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
... Morria Biopharmaceuticals Plc, a,biopharmaceutical company focused on the ... preliminary safety results from its,Phase I safety and ... allergic rhinitis (AR)., MRX-4 was nasally administered ... four,consecutive weeks. The first administration was given without ...
... season, HOFFMAN ESTATES, Ill., Jan. 15 Kmart Pharmacy,today ... "People need to remember that flu season is in ... are lowering prices to encourage more people to,do what they ... Kmart Pharmacy. "While the flu season has not been as ...
Cached Medicine Technology:Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients 2
(Date:5/19/2013)... FL (PRWEB) May 19, 2013 Exciting ... ®, who is reintroducing a great practice known through ... Brushing, also known as dry body brushing, has so ... Heshelow, founder of Sublime Beauty®. "We love that circulation ... of our largest organ, the skin, is supported through ...
(Date:5/19/2013)... Beginning Wednesday, May 29 and running through ... will feature “Hot Dog Wednesdays" and Ice Cold Slushies at ... hot dogs and all the fixin's to donors on Wednesdays. ... the summer. “Donors are our lifeline. The summer months are ... blood supply. This is a small way for us ...
(Date:5/19/2013)... The AMTC team will be screening local Columbus talent at ... Center on June 1st. Professionals and amateurs, ages 4 and ... charge. , Actors, Models and Talent for Christ (AMTC) has ... grads like Caitlin Kinney - SYTYCD, Caleb Callahan - ... on his Liquid Neon 2013 Tour, Taylor Beckham - The ...
(Date:5/19/2013)... Minor fender benders and serious car ... parties to the accident to respond appropriately to the ... Prevention (CDC) data from 2010, accidents, including car accidents, ... In fact, in 2005, automobile accident-related deaths ... than 2.3 million drivers and passengers receive treatment in ...
(Date:5/19/2013)... Columbus, OH (PRWEB) May 19, 2013 ... LLC continue to follow developments in the nation’s first ... The case, underway in Washington State Superior Court, was ... several years after he suffered complications in a robot-assisted ... The Da Vinci robotic surgery lawsuit ...
Breaking Medicine News(10 mins):Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4
... By Switching From Expensive Brand Name Drugs to Equally Effective ... , YONKERS, N.Y., July 8 According to a new ... be skeptical if their doctors offer them free prescription drug ... (ADHD). Free samples can hook consumers on high-priced brand ...
... combining movement and force tax our brains to capacity, ... results from the limits of the muscles themselves. The ... neuromuscular system can at times profoundly affect one,s ability ... part by the National Science Foundation and the National ...
... , WASHINGTON, July 8 The results of a ... British Medical Journal (BMJ) support the findings of a white ... and Security (SCHS) regarding the potentially lifesaving qualities of cholesterol ... report concluded, "In patients without established cardiovascular disease but with ...
... July 8 Governor Edward G. Rendell today announced that ... and the Pennsylvania Emergency Management Agency will participate in a ... 9. , , The Governor said the summit will ... efforts to respond to the current global pandemic and prepare ...
... 8 Today, the American Hospital Association, Federation of ... with the White House and Senate Finance Chairman Max ... billion. Cost savings is an important goal, supported ... representing physician owned hospitals. As always, physician hospitals will ...
... ... organization, launches a new national television advertising campaign calling on Congress to put an ... ... 2009 -- Autism Speaks, the nation,s largest autism science and advocacy organization, today launched ...
Cached Medicine News:Health News:Consumer Reports to Parents: Think Twice About Free Prescription ADHD Drug Samples for Your Children 2Health News:Consumer Reports to Parents: Think Twice About Free Prescription ADHD Drug Samples for Your Children 3Health News:Consumer Reports to Parents: Think Twice About Free Prescription ADHD Drug Samples for Your Children 4Health News:Matter over mind 2Health News:British Medical Journal Report Supports SCHS White Paper on Statins 2Health News:Rendell Administration Officials to Participate in National Flu Summit 2Health News:Physician Hospitals of America Charges: Hospital Associations Bargain Away $155 Billion in Medicare Funding in Attempt to Destroy Physician Hospitals 2Health News:Physician Hospitals of America Charges: Hospital Associations Bargain Away $155 Billion in Medicare Funding in Attempt to Destroy Physician Hospitals 3Health News:Autism Speaks Launches TV Ad Campaign Calling on Congress to End Insurance Discrimination Against Children with Autism 2Health News:Autism Speaks Launches TV Ad Campaign Calling on Congress to End Insurance Discrimination Against Children with Autism 3
Richardson Blade - for use with Bookler Universal Table Mounted Retractor Systems...
Richardson Retractors...
... term being used today to describe the nature of ... may have been used in silicone implants in the ... not new technology cohesive is simply a word ... nature of the gel. All of Mentor silicone gel-filled ...
A full, rounded look that adds greater dimension to the breast. Moderate base, with a higher profile than our Style 1600 implant....
Medicine Products: